[{"Assets_0_Q3_USD":39974000000.0,"CommonStockSharesOutstanding_0_Q3_shares":348582556.0,"EarningsPerShareBasic_1_Q3_USD":3.71,"EarningsPerShareBasic_3_Q3_USD":5.4,"EarningsPerShareDiluted_1_Q3_USD":3.69,"EarningsPerShareDiluted_3_Q3_USD":5.38,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":1712000000.0,"StockholdersEquity_0_Q3_USD":5327000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":352300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":351400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":350400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":350100000.0,"Ticker":"BHC","CIK":"885590","name":"VALEANT PHARMACEUTICALS INTERNATIONAL, INC.","OfficialName":"Bausch Health Companies Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7962573421.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20171107"}]